Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    MYH9 and APOL1 are both associated with sickle cell disease nephropathy.

    Ashley-Koch AE, Okocha EC, Garrett ME, Soldano K, De Castro LM, Jonassaint JC, Orringer EP, Eckman JR, Telen MJ.

    Br J Haematol. 2011 Nov;155(3):386-94. doi: 10.1111/j.1365-2141.2011.08832.x. Epub 2011 Sep 13.

    PMID:
    21910715
    [PubMed - indexed for MEDLINE]
    2.

    Sickle cell nephropathy - a practical approach.

    Sharpe CC, Thein SL.

    Br J Haematol. 2011 Nov;155(3):287-97. doi: 10.1111/j.1365-2141.2011.08853.x. Epub 2011 Sep 9. Review.

    PMID:
    21902687
    [PubMed - indexed for MEDLINE]
    3.

    Tapered oral dexamethasone for the acute chest syndrome of sickle cell disease.

    Quinn CT, Stuart MJ, Kesler K, Ataga KI, Wang WC, Styles L, Smith-Whitley K, Wun T, Raj A, Hsu LL, Krishnan S, Kuypers FA, Setty Y, Rhee S, Key NS, Buchanan GR; Investigators of the Comprehensive Sickle Cell Centers.

    Br J Haematol. 2011 Oct;155(2):263-7. doi: 10.1111/j.1365-2141.2011.08827.x. Epub 2011 Aug 16.

    PMID:
    21848879
    [PubMed - indexed for MEDLINE]
    4.

    Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.

    Pellagatti A, Cazzola M, Giagounidis A, Perry J, Malcovati L, Della Porta MG, Jädersten M, Killick S, Vyas P, Hellström-Lindberg E, Wainscoat JS, Boultwood J.

    Br J Haematol. 2011 Oct;155(2):272-4. doi: 10.1111/j.1365-2141.2011.08672.x. Epub 2011 Apr 15. No abstract available.

    PMID:
    21492127
    [PubMed - indexed for MEDLINE]
    5.

    Chronic myeloid leukaemia and sickle cell disease: could imatinib prevent vaso-occlusive crisis?

    Stankovic Stojanovic K, Thiolière B, Garandeau E, Lecomte I, Bachmeyer C, Lionnet F.

    Br J Haematol. 2011 Oct;155(2):271-2. doi: 10.1111/j.1365-2141.2011.08670.x. Epub 2011 Apr 13. No abstract available.

    PMID:
    21488859
    [PubMed - indexed for MEDLINE]
    6.

    Drug induced immune haemolytic anaemia in the Berlin Case-Control Surveillance Study.

    Garbe E, Andersohn F, Bronder E, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Mayer B, Salama A, Kurtal H.

    Br J Haematol. 2011 Sep;154(5):644-53. doi: 10.1111/j.1365-2141.2011.08784.x. Epub 2011 Jul 12.

    PMID:
    21749359
    [PubMed - indexed for MEDLINE]
    7.

    Molecular analysis of globin gene expression in different thalassaemia disorders: individual variation of β(E) pre-mRNA splicing determine disease severity.

    Tubsuwan A, Munkongdee T, Jearawiriyapaisarn N, Boonchoy C, Winichagoon P, Fucharoen S, Svasti S.

    Br J Haematol. 2011 Sep;154(5):635-43. doi: 10.1111/j.1365-2141.2011.08770.x. Epub 2011 Jul 7.

    PMID:
    21732929
    [PubMed - indexed for MEDLINE]
    8.

    Chelation treatment in sickle-cell-anaemia: much ado about nothing?

    Lucania G, Vitrano A, Filosa A, Maggio A.

    Br J Haematol. 2011 Sep;154(5):545-55. doi: 10.1111/j.1365-2141.2011.08769.x. Epub 2011 Jun 28. Review.

    PMID:
    21707578
    [PubMed - indexed for MEDLINE]
    9.

    Successful chelation therapy with the combination of deferasirox and deferiprone in a patient with thalassaemia major and persisting severe iron overload after single-agent chelation therapies.

    Voskaridou E, Christoulas D, Terpos E.

    Br J Haematol. 2011 Sep;154(5):654-6. doi: 10.1111/j.1365-2141.2011.08626.x. Epub 2011 May 25. No abstract available.

    PMID:
    21615376
    [PubMed - indexed for MEDLINE]
    10.

    Extramedullary haematopoiesis secondary to hereditary spherocytosis.

    Smith J, Rahilly M, Davidson K.

    Br J Haematol. 2011 Sep;154(5):543. doi: 10.1111/j.1365-2141.2011.08692.x. Epub 2011 Apr 22. No abstract available.

    PMID:
    21517821
    [PubMed - indexed for MEDLINE]
    11.

    Regular automated erythrocytapheresis in sickle cell patients.

    Driss F, Moh-Klaren J, Pela AM, Tertian G.

    Br J Haematol. 2011 Sep;154(5):656-9. doi: 10.1111/j.1365-2141.2011.08630.x. Epub 2011 Apr 22. No abstract available.

    PMID:
    21517812
    [PubMed - indexed for MEDLINE]
    12.

    Diagnosis and management of anaemia of chronic disease: current status.

    Cullis JO.

    Br J Haematol. 2011 Aug;154(3):289-300. doi: 10.1111/j.1365-2141.2011.08741.x. Epub 2011 May 25. Review.

    PMID:
    21615381
    [PubMed - indexed for MEDLINE]
    13.

    Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.

    Vichinsky E, Bernaudin F, Forni GL, Gardner R, Hassell K, Heeney MM, Inusa B, Kutlar A, Lane P, Mathias L, Porter J, Tebbi C, Wilson F, Griffel L, Deng W, Giannone V, Coates T.

    Br J Haematol. 2011 Aug;154(3):387-97. doi: 10.1111/j.1365-2141.2011.08720.x. Epub 2011 May 19.

    PMID:
    21592110
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Mild haemorheological changes induced by a moderate endurance exercise in patients with sickle cell anaemia.

    Balayssac-Siransy E, Connes P, Tuo N, Danho C, Diaw M, Sanogo I, Hardy-Dessources MD, Samb A, Ballas SK, Bogui P.

    Br J Haematol. 2011 Aug;154(3):398-407. doi: 10.1111/j.1365-2141.2011.08728.x. Epub 2011 May 14.

    PMID:
    21569006
    [PubMed - indexed for MEDLINE]
    15.

    Transient aplastic crisis as presentation of a previously unknown G6PD deficiency with iron overload.

    Green L, De Lord C, Clark B, Cadet E, Rochette J, Thein SL.

    Br J Haematol. 2011 Aug;154(3):288. doi: 10.1111/j.1365-2141.2011.08666.x. Epub 2011 Apr 27. No abstract available.

    PMID:
    21521183
    [PubMed - indexed for MEDLINE]
    16.

    NT-pro brain natriuretic peptide levels and the risk of death in the cooperative study of sickle cell disease.

    Machado RF, Hildesheim M, Mendelsohn L, Remaley AT, Kato GJ, Gladwin MT.

    Br J Haematol. 2011 Aug;154(4):512-20. doi: 10.1111/j.1365-2141.2011.08777.x. Epub 2011 Jun 21.

    PMID:
    21689089
    [PubMed - indexed for MEDLINE]
    17.

    Methaemalbumin formation in sickle cell disease: effect on oxidative protein modification and HO-1 induction.

    Hanson MS, Piknova B, Keszler A, Diers AR, Wang X, Gladwin MT, Hillery CA, Hogg N.

    Br J Haematol. 2011 Aug;154(4):502-11. doi: 10.1111/j.1365-2141.2011.08738.x. Epub 2011 May 20.

    PMID:
    21595649
    [PubMed - indexed for MEDLINE]
    18.

    Chromosome damage and repair in children with sickle cell anaemia and long-term hydroxycarbamide exposure.

    McGann PT, Howard TA, Flanagan JM, Lahti JM, Ware RE.

    Br J Haematol. 2011 Jul;154(1):134-40. doi: 10.1111/j.1365-2141.2011.08698.x. Epub 2011 May 4.

    PMID:
    21542824
    [PubMed - indexed for MEDLINE]
    19.

    Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment.

    Hodgson K, Ferrer G, Pereira A, Moreno C, Montserrat E.

    Br J Haematol. 2011 Jul;154(1):14-22. doi: 10.1111/j.1365-2141.2011.08707.x. Epub 2011 May 1. Review.

    PMID:
    21534942
    [PubMed - indexed for MEDLINE]
    20.

    Guidelines for supportive care in multiple myeloma 2011.

    Snowden JA, Ahmedzai SH, Ashcroft J, D'Sa S, Littlewood T, Low E, Lucraft H, Maclean R, Feyler S, Pratt G, Bird JM; Haemato-oncology Task Force of British Committee for Standards in Haematology and UK Myeloma Forum.

    Br J Haematol. 2011 Jul;154(1):76-103. doi: 10.1111/j.1365-2141.2011.08574.x. Epub 2011 Apr 22. Review.

    PMID:
    21517805
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk